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Abstract 
Hydrophilic polymers are commonly used as coatings on intravascular medical devices. As intravascular proce-
dures continue to increase in frequency, the risk of embolization of this material throughout the body has be-
come evident. These emboli may be discovered incidentally but can result in serious complications including 
death. Here, we report the first two cases of hydrophilic polymer embolism (HPE) identified on brain tumor re-
section following Wada testing. One patient experienced multifocal vascular complications and diffuse cerebral 
edema, while the other had an uneventful postoperative course. Wada testing is frequently performed during 
preoperative planning prior to epilepsy surgery or the resection of tumors in eloquent brain regions. These cases 
demonstrate the need for increased recognition of this histologic finding to enable further correlation with clin-
ical outcomes. 
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Introduction 
Intravascular devices, such as catheters, guide-
wires, and stents are commonly coated with hydro-
philic polymer material. This hydrophilic polymer 
material has significant procedural benefits, such as 
acting as a lubricant to decrease vascular trauma, 
and reducing vascular spasm.1 Over the past several 
decades there has been a drastic increase in the 
prevalence of minimally invasive endovascular med-
ical procedures. As a result, there has been growing 
recognition of the risk of embolization of hydrophilic 
polymer coating material throughout the body.2,3 
Wada tests (also known as intracarotid sodium 
amobarbital procedure, ISAP) are commonly per-
formed before ablative procedures or resections for 
epilepsy or tumor to assess hemispheric dominance 
Case Report 
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for language. There is a low risk of complications fol-
lowing Wada testing including seizures, status-epi-
lepticus, vascular spasm, and transient encephalo-
pathy.4 Hydrophilic polymer emboli, however, have 
not previously been reported following pre-opera-
tive Wada testing. Here, we describe two patients 
who underwent primary brain tumor resection fol-
lowing Wada testing. In both resection specimens, 
intravascular hydrophilic polymer material with as-
sociated foreign body giant cell reaction was identi-
fied, and in one case there was evidence of associ-
ated acute ischemic change in surrounding neurons. 
To our knowledge, the current work represents the 





A 55-year-old right-handed man presented 
with new-onset generalized tonic-clonic seizures. 
Magnetic resonance imaging (MRI) revealed a non-
enhancing infiltrative and expansile T2-hyperintense 
mass centered within the right superior temporal 
gyrus (Fig. 1a-b). The patient underwent bilateral 
Wada testing. Vascular access was obtained via the 
right femoral artery using the modified Seldinger 
technique. A 5-French angled glide diagnostic cath-
eter was introduced over a 0.035 Terumo Glidewire 
into the descending thoracic aorta and then the cer-
vical internal carotid artery under direct fluoro-
scopic visualization. A Codman Prowler Select Plus 
infusion microcatheter with a Synchro 2 microwire 
was used to catheterize the internal carotid artery 
just distal to the posterior communicating artery. An 
angiographic run was performed to confirm cathe-
ter position prior to Brevital (methohexitol) infusion 
(Fig. 1c). The Wada test demonstrated clear left 
hemisphere language dominance and greater left 
hemisphere memory support. 
Five weeks later, the patient underwent a right 
temporo-parieto-occipital craniotomy for tumor re-
section. His postoperative course was complicated 
by a seizure upon awakening with right frontal ve-
nous infarct and layering remote cerebellar hemor-
rhage. He experienced weakness in his left upper 
and lower extremities and was discharged to a reha-
bilitation facility with antiepileptic and steroid med-
ications. At 5 months follow-up, the patient had re-
covered his motor function with no additional sei-
zures, was able to walk over a mile per day without 
assistance and was tolerating adjuvant chemoradia-
tion. Subsequently, post-treatment MRIs demon-
strated a heterogeneously enhancing, centrally ne-
crotic mass in the right temporo-parietal tumor bed 
with no associated hyperperfusion, characteristic of 
evolving pseudoprogression. These findings were 
associated with marked hemispheric cerebral 
edema refractory to steroid treatment and requiring 
bevacizumab (Fig. 2). 
Pathology: 
Evaluation of the primary resection specimen 
revealed a moderately to highly cellular diffusely in-
filtrating glioma. There was significant pleo-
morphism and focally frequent mitoses, but no mi-
crovascular proliferation or necrosis, meeting histo-
logic criteria for anaplastic astrocytoma, WHO Grade 
III (Fig. 1d-e). Molecular analysis by next-generation 
sequencing (NGS) and microarray revealed features 
of primary IDH-wildtype glioblastoma, including 
EGFR amplification, and the tumor was upgraded to 
WHO Grade IV.5 Additionally noted on pathologic 
examination were scattered foci of giant cell vascu-
litis and intravascular foreign material. The foreign 
material was granular, blue-gray and non-polariza-
ble, morphologically consistent with hydrophilic pol-
ymer material. No surrounding ischemic changes 
were identified (Fig. 1f-g). 
Case 2 
Clinical Findings: 
A 24-year-old right-handed female with no sig-
nificant past-medical history presented after suffer-
ing a generalized tonic-clonic seizure at work. MRI 
showed a large, non-enhancing infiltrative T2 hyper-
intense mass centered in the right hippocampus and 
inferior temporal lobe with regional mass effect (Fig. 
3a-b). She underwent stereotactic biopsy at an out-
side facility, which demonstrated a WHO Grade II 
diffuse astrocytoma. 
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Figure 1: Case 1 Imaging and Pathology. (A) Axial T2-FLAIR and (B) T1 post-contrast sequences of a brain MRI demonstrating a non-
enhancing infiltrative and expansile T2-hyperintense mass centered within the right superior temporal gyrus. (C) A PA view of digital 
subtraction angiogram demonstrating a microcatheter within the right internal carotid artery. (D-E) The tumor resection demonstrates a 
moderately to highly cellular infiltrating glioma, with significant nuclear atypia and scattered mitoses (arrow). (F-G) Parenchymal vessels 
within the resection display giant cell vasculitis and contain basophilic granular foreign material consistent with hydrophilic polymer. 
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Figure 2: Case 1 Post-treatment imaging findings. An 8-month post-operative MRI following chemo-radiation showed evidence of pseu-
doprogression with significant associated cerebral edema. Axial T1 post-contrast (A) shows a heterogeneously enhancing, centrally ne-
crotic mass, with restricted diffusion on DWI (B), and no associated hyperperfusion (C). 
 
 
The patient underwent bilateral Wada testing 
with the same microcatheterization technique de-
scribed in Case 1 (Fig. 3c). Injections of both sodium 
methohexital (Brevital) and amobarbitol (Amytal) 
were completed, and language representation was 
identified in the left hemisphere. Three weeks later, 
the patient underwent right frontotemporal craniot-
omy for tumor resection. She had an uncomplicated 
postoperative course and was discharged home on 
postoperative day 3 at her baseline functional sta-
tus, with no neurologic deficits. She remains neuro-
logically intact and seizure-free 9 months postoper-
atively. 
Pathology: 
Histologic examination of the resection speci-
men showed a paucicellular infiltrating glioma com-
posed of atypical astrocytes with enlarged, irregular, 
and hyperchromatic nuclei. No mitoses, necrosis, or 
microvascular proliferation were detected (Fig. 3d-
e). NGS was performed and an IDH1-R132H muta-
tion was identified, along with mutations in TP53, 
and ATRX. The final diagnosis was diffuse astrocy-
toma, IDH-mutant, WHO Grade II. Also noted multi-
focally were a few small parenchymal vessels con-
taining non-polarizable granular blue-gray foreign 
material consistent with HPE. Surrounding these 
vessels was foreign-body giant cell reaction, and a 
few hyper-eosinophilic acutely ischemic neurons 
(Fig. 3f-g). 
Discussion 
Hydrophilic polymer embolization in cerebral 
vessels was first reported in 1997 by Barnwell et al. 
in four cases involving use of a microcatheter with 
hydrophilic coating for cerebral angiography (three 
autopsy specimens after endovascular thrombolysis 
for acute ischemic stroke, and one biopsy specimen 
of a previously-embolized meningioma).6 Emboli 
were described as basophilic and granular, identical 
in histologic appearance to hydrophilic polymer ma-
terial seen on sections of microcatheter submitted 
for histologic analysis. HPE have since been identi-
fied widely throughout the body, including the 
lungs, skin, heart, and central nervous system 
(CNS).3,7–11 
HPE may be discovered incidentally or in asso-
ciation with a wide range of complications. Reported 
sequelae of HPE throughout the body include vascu-
litis, thrombosis, infarction, and even death.12 Addi-
tionally, there is a significant range in the  
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Figure 3: Case 2 Imaging and Pathology. (A) Axial T2-FLAIR and (B) T1 post-contrast MRI brain sequences demonstrate a non-enhancing 
infiltrative T2 hyperintense mass centered in the right hippocampus and inferior temporal lobe. (C) PA view of a digital subtraction angi-
ogram demonstrates a microcatheter within the left internal carotid artery. (D) The tumor resection shows a moderately cellular glioma 
infiltrating white matter and (E) cortex with perineuronal satellitosis. (F) A hypereosinophilic ischemic neuron (arrow and inset) is seen 
next to a vessel occluded by hydrophilic polymer material with associated inflammation. (G) Some vessels contain multinucleate foreign-
body giant cells consuming basophilic polymer material. 
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time-course of presentation and duration, spanning 
acute, subacute, and delayed symptomatology. One 
study described evidence of persistent inflammation 
over three years after the intravascular procedure.13 
HPE has been reported following various 
neuro-interventional procedures such as aneurysm 
coil embolization, aneurysm flow diversion, intra-ar-
terial thrombolysis, and diagnostic cerebral angi-
ography, and may result in a variety of CNS compli-
cations.12,14,15 Mehta et al. reported a series of 32 
cases of HPE within the CNS, with findings including 
vasculitis, granuloma formation, chemical meningi-
tis, ischemia, and hemorrhage.8 These findings were 
associated with a 38% incidence of stroke and 28% 
rate of death. The high rate of morbidity and mor-
tality secondary to HPE in this study, however, may 
be an overestimate as patients were identified in 
part by their adverse clinical outcome, and types of 
catheterization also included central venous access 
and hemodialysis catheterization. 
Here, we report two cases of HPE identified in 
brain tumor resection following pre-operative Wada 
testing. To perform a Wada test, sodium methohex-
ital (Brevital) or amobarbital (Amytal) is injected into 
right or left internal carotid artery, which results in 
ipsilateral hemispheric anesthetization. At our insti-
tution, a Neuropsychologist conducts a baseline 
evaluation prior to Wada testing, and then repeats 
this assessment during injections of each hemi-
sphere. In addition, an Epileptologist interprets the 
continuous EEG and compares background activity 
in each hemisphere to activity during injection to 
confirm appropriate post-anesthetic changes. A va-
riety of microcatheters are utilized at our institution, 
including the Prowler Select Plus which is a 
braid/coil microcatheter with a radiopaque tip and 
hydrophilic coating. To our knowledge, no prior re-
ports have described an association between this 
microcatheter and HPE. 
The rate of complications following cerebral 
angiography is between 0.3-1.3%, and only a frac-
tion of these are neurologic complications with last-
ing effects.16,17 The complication rate for Wada test-
ing is likely around 2%, although some studies have 
reported up to 10%.4 Of particular interest, our pa-
tient from Case 1 suffered immediate post-craniot-
omy vascular complications possibly induced or ex-
acerbated by HPE-associated vasculitis and throm-
bosis, although there were no immediate or delayed 
complications from the Wada test on its own. Alt-
hough this patient had recovery of neurological 
function and was ambulatory and independent with 
activities of daily living, he had early radiologic evi-
dence of pseudoprogression complicated by cere-
bral edema refractory to steroid treatment and re-
quiring bevacizumab. Though one can only specu-
late, as no additional tissue resection was per-
formed following chemo-radiation, it is possible HPE 
associated vascular changes in this patient may have 
also contributed to his significant refractory cerebral 
edema and extent of pseudoprogression. The pa-
tient from Case 2 has suffered no adverse clinical se-
quela to date despite histologic evidence of vascu-
litis and surrounding acute ischemia. 
HPE-induced vasculitis and thrombosis may 
contribute to surgical and post-operative vascular 
complications in patients undergoing craniotomy for 
tumor resection or during epilepsy surgery. As the 
clinical sequelae of hydrophilic polymer emboli can 
be quite severe based on the findings of several case 
series,8,12 clinicians and surgeons should be made 
aware of their presence when identified histologi-
cally. Therefore, we recommend including the pres-
ence of HPE and any associated vascular or ischemic 
changes as a separate diagnostic line in pathology 
reports when identified in biopsy or resection spec-
imens to allow for clinical correlation in the event of 
any unforeseen vascular complications (See exam-
ple below, Case 2). 
Right temporal brain mass, resection:  
- Integrated Diagnosis: Astrocytoma, IDH-mutant, 
WHO Grade II.  
- Histological Diagnosis: Diffuse astrocytoma. 
- Histological Grade: WHO Grade II. 
- Molecular Information: Molecular alterations in-
cluding: Activating mutation of IDH1 (R132H), and 
inactivating mutations of TP53 and ATRX.  
- Hydrophilic polymer emboli with associated giant 
cell vasculitis and focal acute ischemic changes (See 
comment).  
 
COMMENT: Hydrophilic polymers are applied as surface 
coatings on vascular devices, and embolization of this ma-
terial has been reported following various vascular proce-
dures. Hydrophilic polymer emboli may be an incidental 
finding, but can also result in a range of vascular compli-
cations. Clinical correlation is suggested. 
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Furthermore, the incidence of HPE following 
neuro-interventional procedures is likely under-rec-
ognized. Published studies are limited by selection 
bias; however, and neither the overall rate of HPE 
after cerebral angiography nor the true rate of clini-
cal complications in the setting of cerebral HPE can 
be identified from the current literature. As such, it 
is important to recognize HPE histologically so that 
prospective clinical outcome studies of patients un-
dergoing neuroendovascular procedures prior to 
cerebral tissue biopsy may be performed. 
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